Vaccines

Vaccine Recommendation Strategy

Illustrate the value of your product and ensure its inclusion of your product in the national recommendations

Tailored strategy from in-house experts

Securing recommendation for your vaccine requires an understanding of the market and health system dynamics. Work closely with our in-house experts to create a tailored strategy designed to navigate market access efficiently and gaining the recommendations to make your product available to patients.

The right strategy drives timing, access, and profitability, and helps you to protect the patients’ lives more effectively.

Why choose Alira Health?

When it comes to strategic planning, you’ll benefit from our:

  • Ability to gain full understanding of your products’ value and to effectively incorporate it into the recommendation strategy
  • Focused attention on your specific needs and individual aspects of your vaccine
  • In-house industry experts with over 25 years of experience working with the key market stakeholders—from payers to doctors
  • In-depth knowledge of industry challenges—and how to meet them

Working together to transform healthcare

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Bernd Schollmeier
Bernd Shollmier
Vice President of Global Market Access Vaccines
We are seeing a lot of traction in the industry, as well as interest in vaccine production. To support companies in a challenging payer environment, we created a dedicated vaccine division in our Global Market Access department to provide a variety of solutions that maximize patient access and the gross-to-net value of the product across the full product lifecycle.

Related News

Multimedia May 26, 2023
Webinar on Advancing Patient Engagement in the Medical Device / MedTech Industry
Engaging with patients, including their caregivers and advocates, is crucial during the planning and execution of clinical trials.
Medical Devices MedTech Patient Engagement
Blog May 17, 2023
Introduction to Patient Engagement in MedTech in the U.S.
Check out these key takeaways from our Playbook for Patient Engagement in MedTech in the U.S. and access the playbook download.
MedTech Patient Engagement USA
Events April 26, 2023
MedTech Forum 2023
We are excited to share that we will be sponsoring and speaking at MedTech Forum 2023. The MedTech Forum is the largest health and medical technology industry conference in Europe and(...)
MedTech Real-World Evidence (RWE)
Publications April 25, 2023
Comprehensive Guide to the Content of Integrated Summaries of Efficacy and Safety (ISE/ISS)
Read this to discover the content of Integrated Summaries of Efficacy and Safety (ISE/ISS).
MedTech
Events April 18, 2023
MedTech Impact Gala 2023
We are excited to share that we will sponsor and speak at MedTech Impact Symposium 2023.  The Symposium is organized by Massachusetts Medical Device Industry Council (MassMEDIC) and(...)
Medical Devices MedTech
Events April 18, 2023
MedTech Impact Symposium 2023
We are excited to share that we will sponsor and speak at MedTech Impact Symposium 2023.  The Symposium is organized by Massachusetts Medical Device Industry Council (MassMEDIC) and(...)
Medical Devices MedTech
Blog April 17, 2023
Reimbursement of Rare Disease Drugs in Italy: Challenges and Hopes for the Future
When it comes to rare diseases, Italy has done a good job in bringing EMA-approved drugs, including orphan drugs, to the Italian market. But  multiple challenges exist, many of which(...)
Italy Market Access Pharma Rare Disease Real-World Evidence (RWE)
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.